1887

Journal of General Virology header logo

Volume 80, Issue 9

The appearance of escape variants does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus Free

Abstract

The presence or evolution of immune escape variants has been proposed to account for the failure of recombinant envelope vaccines to protect macaques against challenge with simian immunodeficiency virus (SIVmac). To address this issue, two groups of three cynomolgus macaques were immunized with recombinant SIV Env vaccines using two different vaccine schedules. One group of macaques received four injections of recombinant SIV gp120 in SAF-1 containing threonyl muramyl dipeptide as adjuvant. A second group were primed twice with recombinant vaccinia virus expressing SIV gp160 and then boosted twice with recombinant SIV gp120. Both vaccine schedules elicited neutralizing antibodies to Env. However, on the day of challenge, titres of anti-Env antibodies measured by ELISA were higher in macaques primed with recombinant vaccinia virus. Following intravenous challenge with 10 monkey infectious doses of the SIVmac J5M challenge stock, five of the six immunized macaques and all four naive controls became infected. The virus burdens in PBMC of macaques that were primed with recombinant vaccinia virus were lower than those of naive controls, as determined by virus titration and quantitative DNA PCR. Sequence analysis was performed on SIV amplified from the blood of immunized and naive infected macaques. No variation of SIV sequence was observed, even in macaques with a reduced virus load, suggesting that the appearance of immune escape variants does not account for the incomplete protection observed. In addition, this study indicates that the measurement of serum neutralizing antibodies may not provide a useful correlate for protection elicited by recombinant envelope vaccines.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-9-2375
1999-09-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/9/0802375a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-9-2375&mimeType=html&fmt=ahah

References

  1. Ahmad S., Lohman B., Marthas M., Giavedoni L., el-Amad Z., Haigwood N. L., Scandella C. J., Gardner M. B., Luciw P. A., Yilma T. 1994; Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses 10:195–204
     [Google Scholar]
  2. Almond N., Jenkins A., Slade A., Heath A., Cranage M., Kitchin P. 1992; Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies. AIDS Research and Human Retroviruses 8:77–88
     [Google Scholar]
  3. Almond N., Jenkins A., Heath A. B., Kitchin P. 1993; Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region. Journal of General Virology 74:865–871
     [Google Scholar]
  4. Almond N., Rose J., Sangster R., Silvera P., Stebbings R., Walker B., Stott E. J. 1997; Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. Journal of General Virology 78:1919–1922
     [Google Scholar]
  5. Berman P. W., Gray A. M., Wrin T., Vennari J. C., Eastman D. J., Nakamura G. R., Francis D. P., Gorse G., Schwartz D. H. 1997; Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers. Journal of Infectious Diseases 176:384–397
     [Google Scholar]
  6. Burns D. P., Desrosiers R. C. 1991; Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. Journal of Virology 65:1843–1854
     [Google Scholar]
  7. Clements J. E., Montelaro R. C., Zink M. C., Amedee A. M., Miller S., Trichel A. M., Jagerski B., Hauer D., Martin L. N., Bohm R. P., Murphy-Corb M. 1995; Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. Journal of Virology 69:2737–2744
     [Google Scholar]
  8. Clerici M., Shearer G. M. 1994; The Th1-Th2 hypothesis of HIV infection: new insights. Immunology Today 15:575–581
     [Google Scholar]
  9. Connor R. I., Korber B. T., Graham B. S., Hahn B. H., Ho D. D., Walker B. D., Neumann A. U., Vermund S. H., Mestecky J., Jackson S., Fenmore E., Cao Y., Gao F., Kalams S., Kunstman K. J., McDonald D., McWilliams N., Trkola A., Moore J. P., Wolinsky S. M. 1998; Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. Journal of Virology 72:1552–1576
     [Google Scholar]
  10. Daniel M. D., Mazzara G. P., Simon M. A., Sehgal P. K., Kodama T., Panicali D. L., Desrosiers R. C. 1994; High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Research and Human Retroviruses 10:839–851
     [Google Scholar]
  11. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J., McMichael A., Gotch F. 1995; Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1:1167–1173
     [Google Scholar]
  12. Gardner M., Rosenthal A., Jennings M., Yee J., Antipa L., Robinson E. Jr 1995; Passive immunization of rhesus macaques against SIV infection and disease. AIDS Research and Human Retroviruses 11:843–854
     [Google Scholar]
  13. Giavedoni L. D., Planelles V., Haigwood N. L., Ahmad S., Kluge J. D., Marthas M. L., Gardner M. B., Luciw P. A., Yilma T. D. 1993; Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. Journal of Virology 67:577–583
     [Google Scholar]
  14. Haigwood N. L., Watson A., Sutton W. F., McClure J., Lewis A., Ranchalis J., Travis B., Voss G., Letvin N. L., Hu S.-L., Hirsch V. M., Johnson P. R. 1996; Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunology Letters 51:107–114
     [Google Scholar]
  15. Hirsch V. M., Fuerst T. R., Sutter G., Carroll M. W., Yang L. C., Goldstein S., Piatak M. Jr, Elkins W. R., Alvord W. G., Montefiori D. C., Moss B., Lifson J. D. 1996; Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. Journal of Virology 70:3741–3752
     [Google Scholar]
  16. Horth M., Lambrecht B., Khim M. C., Bex F., Thiriart C., Ruysschaert J.-M., Burny A., Brasseur R. 1991; Theoretical and functional analysis of the SIV fusion peptide. EMBO Journal 10:2747–2755
     [Google Scholar]
  17. Hu S.-L., Klaniecki J., Dykers T., Sridhar P., Travis B. M. 1991; Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Research and Human Retroviruses 7:615–620
     [Google Scholar]
  18. Hu S.-L., Abrams K., Barber G. N., Moran P., Zarling J. M., Langlois A. J., Kuller L., Morton W. R., Benveniste R. E. 1992; Protection of macaques against SIV infection by subunit vaccines of the SIV envelope glycoprotein gp160. Science 255:456–459
     [Google Scholar]
  19. Hulskotte E. G., Geretti A.-M., Siebelink K. H., van Amerongen G., Cranage M. P., Rud E. W., Norley S. G., de Vries P., Osterhaus A. D. 1995; Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5. Journal of Virology 69:6289–6296
     [Google Scholar]
  20. Israel Z. R., Edmonson P. F., Maul D. H., O’Neil S. P., Mossman S. P., Thiriart C., Fabry L., Van Opstal O., Bruck C., Bex F., Burny A., Fultz P., Mullins J., Hoover E. 1994; Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. Journal of Virology 68:1843–1853
     [Google Scholar]
  21. Johnson P. R., Hamm T. E., Goldstein S., Kitov S., Hirsch V. M. 1991; The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 185:217–228
     [Google Scholar]
  22. Jones W. C., Barnard A. L., Slade A., Mills K. H. G. 1992; Heterogeneity in the recognition of the simian immunodeficiency virus envelope glycoprotein by CD4+ T cell clones from immunized macaques. Journal of Immunology 149:3120–3126
     [Google Scholar]
  23. Kent K. A., Kitchin P., Mills K. H., Page M., Taffs F., Corcoran T., Silvera P., Flanagan B., Powell C., Rose J., Ling C., Aubertin A., Stott E. J. 1994; Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Research and Human Retroviruses 10:189–194
     [Google Scholar]
  24. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R., Klavinskis L., Jones I., Doyle C., Ward R. 1996; Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Medicine 2:767–775
     [Google Scholar]
  25. Mellors J. W., Rinaldo C. R. Jr, Gupta P., White R. M., Todd J. A., Kingsley L. A. 1996; Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167–1170
     [Google Scholar]
  26. Mills K. H. G., Page M., Chan W. L., Kitchin P., Stott E. J., Taffs F., Jones W., Rose J., Ling C., Silvera P., Corcoran T., Flanagan B., Burny A., Bex F., Delchambre M., Van Opstal O., Fabry L., Thiriart C., Delers A., De Wilde M., Bruck C. 1992; Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins. Journal of Medical Primatology 21:50–58
     [Google Scholar]
  27. Polacino P., Stallard V., Klaniecki J. E., Montefiori D. C., Langlois A. J., Richardson B. A., Overbaugh J., Morton W. R., Benveniste R. E., Hu S.-L. 1999; Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. Journal of Virology 73:618–630
     [Google Scholar]
  28. Putkonen P., Thorstensson R., Ghavamzadeh L., Albert J., Hild K., Biberfeld G., Norrby E. 1991; Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 352:436–438
     [Google Scholar]
  29. Rose J., Silvera P., Flanagan B., Kitchin P., Almond N. 1995; The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. Journal of Virological Methods 51:229–239
     [Google Scholar]
  30. Rud E. W., Cranage M., Yon J., Quirk J., Ogilvie L., Cook N., Webster S., Dennis M., Clarke B. E. 1994; Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. Journal of General Virology 75:529–543
     [Google Scholar]
  31. Slade A., Jones S., Jenkins A., Bootman J., Heath A., Kitchin P., Almond N. 1995; Similar patterns of simian immunodeficiency virus env sequences are found in the blood and lymphoid tissues of chronically infected macaques. AIDS Research and Human Retroviruses 11:1509–1516
     [Google Scholar]
  32. Stott E., Almond N. 1995; Assessing animal models of AIDS. Nature Medicine 1:295–297
     [Google Scholar]
  33. Stott E. J., Chan W. L., Mills K. H., Page M., Taffs F., Cranage M., Greenaway P., Kitchin P. 1990; Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet 336:1538–1541
     [Google Scholar]
  34. Watson A., Ranchalis J., Travis B., McClure J., Sutton W., Johnson P. R., Hu S.-L., Haigwood N. L. 1997; Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. Journal of Virology 71:284–290
     [Google Scholar]
  35. Wyand M. S., Manson K. H., Garcia-Moll M., Montefiori D., Desrosiers R. C. 1996; Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. Journal of Virology 70:3724–3733
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-9-2375
Loading
The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus
J. Gen. Virol. 80, 2375 (1999); https://doi.org/10.1099/0022-1317-80-9-2375
/content/journal/jgv/10.1099/0022-1317-80-9-2375
/content/journal/jgv/10.1099/0022-1317-80-9-2375
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error